Remove 2020 Remove Chemotherapy Remove Compounding
article thumbnail

Ipsen to buy biopharmaceutical company Epizyme for $247m

Pharmaceutical Technology

The transaction is focused on Epizyme’s lead asset, Tazverik (tazemetostat), a chemotherapy-free EZH2 a inhibitor. In 2020, the US Food and Drug Administration (FDA) granted accelerated approval for the drug. The company will begin an all-cash tender offer through its subsidiary to buy Epizyme’s all outstanding shares for $1.45

article thumbnail

Safe Handling of Hazardous Drugs

RX Note

Workplace activity involves how healthcare workers use and handle the drug in the workplace - such as opening shipments, compounding, administering or cleaning up after use or spills. Oral hazardous drugs No crushing or compounding may be done in an unprotected environment.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Hospital Pharmacy FAQ

RX Note

You may also refresh knowledge of clinical pharmacokinetics , total parenteral nutrition or chemotherapy before entering the relevant rotations. You should be at least familiar with insulin and inhalers counselling before entering ward, inpatient or outpatient. What to do if I did not know the answer to questions from patients or doctors?

article thumbnail

Solutions for Constipation Relief

The Thyroid Pharmacist

According to a 2020 study, there seems to be a connection between hemorrhoids and Hashimoto’s. [23] Chemotherapy agents: Chemotherapy agents can lead to constipation in a variety of ways such as slowing the movements of the intestinal tract or creating inflammation that disrupts digestive function. Nat Microbiol. Freece.com.;

article thumbnail

How Myo-inositol Can Improve Hashimoto’s Symptoms

The Thyroid Pharmacist

While the human body (via the liver and kidneys) can produce up to 4 g/day of inositol, it has been found that the overly processed, high glucose (and low fiber) Western diets that many people follow, only provide about 1 g/day of the compound. (7). Published 2020 May 12. Published 2020 Nov 24. 2020;12(5):e8079.

article thumbnail

2020 review – Pharma’s progress outside of COVID-19

pharmaphorum

2020 also saw some of the first “tumour agnostic” cancer drugs get to market, with Bayer’s Vitravki (larotrectinib) getting funding in the UK for tumours with confirmed neurotrophic tyrosine receptor kinase (NTRK) gene fusions.”. months in patients treated with chemotherapy. billion on buying the US biotech VelosBio in November.

article thumbnail

Not every cough is COVID – MSD UK’s lung cancer campaign

pharmaphorum

In December 2020, MSD UK targeted the North East of England with a campaign urging people to remember “not every cough is COVID” and visit their GP if they had a cough for more than three weeks. MSD will continue to work with the NHS looking at how the lung cancer pathway can be improved.